ACST: Average Analyst Price Target is $6 - StockNews?

ACST: Average Analyst Price Target is $6 - StockNews?

WebFeb 20, 2024 · Acasti Pharma Inc. (NASDAQ:ACST)’s beta value is holding at 1.16, while the average true range (ATR) indicator is currently reading 0.05. Considering analysts have assigned the stock a price target range of $1.87-$2.40 as the low and high respectively, we find the trailing 12-month average consensus price target to be $2.09. 84 warrick street coquitlam WebThe Trend in the Analyst Price Target. ACST's average price target has moved up $2.04 over the prior 20 months. Over the past 44 weeks, ACST's average upside potential has been 404.82%. Date. WebMar 24, 2024 · H.C. Wainwright analyst Oren Livnat reiterated a Buy rating on Acasti Pharma (ACST - Research Report) today and set a price target of $2.40. The company's shares closed yesterday at $0.53.According to TipRanks, Livnat is an analyst with an average return of -4.4% and a 39.72% success rate. Livnat covers the Healthcare sector, … 84 web employee login WebThe Trend in the Analyst Price Target. ACST's average price target has moved up $2.04 over the prior 20 months. Over the past 44 weeks, ACST's average upside potential has … WebPrice target. 2.09 0.00 0.00%. The 3 analysts offering 1 year price forecasts for ACST have a max estimate of — and a min estimate of —. ... See Acasti Pharma, Inc. stock price prediction for 1 year made by analysts and compare it to price changes over time to develop a better trading strategy. 84 w champions blvd rogers ar WebAcasti Pharma Reports Third Quarter 2024 Operational Results. Company to Host Conference Call Today at 1:00pm ET LAVAL, Québec, Feb. 14, 2024 (GLOBE NEWSWIRE) -- Acasti Pharma Inc. (“Acasti” or the “Company”) (Nasdaq: ACST and TSX-V: ACST), a late-stage, specialty pharma company advancing three clinical stage drug candidates …

Post Opinion